The Scripps Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile

The Scripps Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH138351D
  • |
  • Pages: 135
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institute offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. It also offers undergraduate, graduate and postdoctoral programs. TSRI also organizes academic preparation and educational outreach programs. The institute operates through its research centers and institutes including Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.

The Scripps Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deal Details 15

Partnerships 15

Pfizer Enters into Licensing Agreement with Scripps Research Institute 15

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 15

HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 16

Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17

Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18

Scripps Research Institute, ZIP and IME Enter into Partnership 19

aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 20

Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 21

Scripps Research Institute Expands Research Agreement With Takeda 22

Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 23

Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 24

ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 25

Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 26

LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 26

Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 27

Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 28

Licensing Agreements 29

Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 29

BlinkBio Enters into Option agreement with Scripps Research Institute 30

iGenomX Enters into Licensing Agreement with Scripps Research Institute 31

OPKO Health Enters into Licensing Agreement with Scripps Research Institute 31

Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 32

Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 33

Fabrus Enters into Licensing Agreement with Scripps Research Institute 34

Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 35

Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 36

Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 37

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 38

Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 39

Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 40

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 41

OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 41

Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 42

Equity Offering 43

Blackthorn Therapeutics Spin Off from Scripps Research Institute 43

The Scripps Research Institute-Key Competitors 45

Key Employees 46

Locations And Subsidiaries 47

Head Office 47

Other Locations & Subsidiaries 47

Recent Developments 48

Corporate Communications 48

Jun 01, 2016: TSRI Appoints Richard King as Chief Operating Officer 48

Government and Public Interest 49

May 04, 2017: Scientists Solve Major Cancer Protein Conundrum 49

Mar 27, 2017: Scientists discover new class of anti-diabetes compounds that reduce liver glucose production 50

Feb 14, 2017: Scripps Florida Collaboration Awarded $3.3 Million to Develop Next-Generation Breast Cancer Therapies 51

Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 52

Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 54

Jan 24, 2017: Scripps Florida team awarded $1.8 million grant to develop drugs for heart disease and rheumatoid arthritis 55

Dec 29, 2016: Scripps Florida scientists uncover new way to defeat therapy-resistant prostate cancer 56

Dec 22, 2016: TSRI study: Protein monitors lung volume and regulates breathing 57

Dec 12, 2016: Study shows aging process increases DNA mutations in important type of stem cell 59

Dec 07, 2016: Scripps Florida Scientists Uncover Potential Driver of Age- and Alzheimer's-Related Memory Loss 60

Oct 17, 2016: Scripps Florida Scientists Uncover New Facets of Zika-Related Birth Defects to Help Develop Treatment 61

Oct 13, 2016: Scripps Florida Scientists Awarded Special Grant to Develop Memory-Altering Medication for Addiction 62

Oct 12, 2016: Scientists Identify Potent New Anti-Obesity, Anti-Diabetes Target 63

Oct 05, 2016: Grant to TSRI-Led Consortium Expands to $207 Million 64

Sep 12, 2016: TSRI scientists discover antibodies that target holes in HIV's defenses 65

Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 66

Sep 01, 2016: New TSRI Method Makes Building 'One-Handed' Drugs Easier than Ever 68

Aug 11, 2016: New Study Shines Light on Mutations Responsible for Debilitating Heart Conditions 70

Aug 02, 2016: TSRI Researchers Find 'Lead Actors' in Immune Cell Development 71

Aug 01, 2016: A Potential New Way to Sway the Immune System 73

Jul 20, 2016: TSRI team finds potential drug candidates that could intervene in deadly diseases 74

Jul 07, 2016: Walgreens to Participate in U.S. Precision Medicine Initiative Cohort Program through The Scripps Research Institute 76

Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 77

Jun 28, 2016: TSRI scientists stabilize HIV structure, design potential AIDS vaccine candidates 79

Jun 27, 2016: TSRI scientists find new cancer drug target in dual-function protein 81

Jun 23, 2016: TSRI Scientists Reveal Single-Neuron Gene Landscape of the Human Brain 82

Jun 15, 2016: New TSRI Method Opens Door to Development of Many New Medicines 83

Jun 07, 2016: Scripps Florida Scientists Awarded $1.3 Million to Optimize Chemical Probes to Test an Innovative Approach to Cancer Treatment 85

May 26, 2016: TSRI Scientists Discover Mechanism that Turns Mutant Cells into Aggressive Cancers 86

May 09, 2016: Scripps Florida scientists pioneer a breakthrough approach to breast cancer treatment 87

Apr 27, 2016: TSRI, Harvard, Stanford and Brandeis Collaborate to Study MicroRNA's Role in Memory, Sleep and Synapse Function 88

Apr 21, 2016: New Molecule-Building Method from TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries 89

Apr 14, 2016: Scripps Florida Study Identifies Memory Suppressor Gene That Could Hold Key to New Alzheimer's Disease Treatments 91

Apr 05, 2016: TSRI scientists get first-ever glimpse of 'teenage' HIV-neutralizing antibody 92

Apr 04, 2016: TSRI Scientists: Immune Cell Transforms from 'Clark Kent' to 'Superman' 94

Mar 31, 2016: Scripps Florida Team Awarded $3.4M to Develop Treatments for Addiction, Mood Disorders 95

Mar 28, 2016: TSRI, Salk Scientists Discover 'Outlier' Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation 96

Mar 18, 2016: Scripps Florida Scientists Win $1.4 Million Grant to Develop New Ways to Block Breast Cancer 98

Mar 10, 2016: TSRI study identifies new type of protein clump that may be implicated in ALS 99

Mar 09, 2016: Scripps Florida study lays groundwork for potential bipolar disorder therapies 100

Mar 08, 2016: Scripps Florida Scientists Win $2.4 Million to Develop New Strategies to Fight Obesity 101

Feb 29, 2016: Scripps Florida Scientists Find Way to Predict Activity of Stem Cells 102

Feb 24, 2016: Scripps Florida Scientists Awarded $2.25 Million to Study Key Mechanisms Behind Some Cancers 103

Feb 19, 2016: TSRI and JCVI scientists find popular stem cell techniques safe 104

Feb 18, 2016: Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor 105

Feb 16, 2016: TSRI Scientists Create Vaccine Against Dangerous Designer Opioids 107

Feb 12, 2016: Scripps Florida Scientists Win $1.7 Million Grant to Advance New Strategies to Treat Huntington's Disease 108

Feb 11, 2016: Scripps Florida scientists identify a memory suppressor that may play a role in autism 109

Feb 03, 2016: Scripps Florida Scientists Win $1.2 Million to Study New Strategies for Treating Obesity, Diabetes, Cardiovascular Disease and Muscle Decline 110

Jan 27, 2016: Philanthropist Samuel Yin Provides $12.8 Million Gift for New Laboratories at The Scripps Research Institute 111

Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 112

Jan 14, 2016: TSRI Researchers Develop Versatile New Way to Build Molecules 114

Jan 12, 2016: TSRI Chemists Awarded $2.1 Million to Create Potential New Therapies with Click Chemistry 116

Product News 117

Dec 29, 2016: Scripps Florida scientists develop drug discovery approach to predict health impact of endocrine-disruptors 117

Dec 20, 2016: Scripps Florida scientists discover new natural source of potent anti-cancer drugs 119

Dec 12, 2016: TSRI scientists devise new approaches to personalized medicines 120

Nov 21, 2016: Scripps Florida Scientists Create Innovative Drug Design Strategy to Improve Breast Cancer Treatment 121

May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 122

Mar 31, 2016: TSRI-Calibr Team Creates Novel Platform for Generating Long-Acting Drug Candidates 123

Mar 28, 2016: A Novel Peptide Engineering Platform for Generating Stapled Long-acting Peptide Hormones 124

Mar 24, 2016: New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial 125

Mar 23, 2016: TSRI Chemists Find a Way to Synthesize Complex Plant Molecule Phorbol and Its Derivatives 126

03/16/2017: Scripps Florida scientists develop new drug delivery method for cancer therapy 128

Mar 09, 2017: Potential drug candidates halt prostate and breast cancer growth 129

Jan 28, 2016: TSRI Study Reveals Workings of Mysterious 'Relief Valve' that Protects Cells from Swelling 130

Jan 14, 2016: TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules 132

Jan 14, 2016: California Institute for Biomedical Research releases a pair of research articles describing a novel switchable CAR-T cell platform to treat cancer 134

Appendix 135

Methodology 135

About GlobalData 135

Contact Us 135

Disclaimer 135

List of Figures

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11

List of Tables

The Scripps Research Institute, Pharmaceuticals & Healthcare, Key Facts 1

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

The Scripps Research Institute, Deals By Therapy Area, 2011 to YTD 2017 10

The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Pfizer Enters into Licensing Agreement with Scripps Research Institute 15

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 15

HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 16

Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17

Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18

Scripps Research Institute, ZIP and IME Enter into Partnership 19

aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 20

Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 21

Scripps Research Institute Expands Research Agreement With Takeda 22

Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 23

Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 24

ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 25

Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 26

LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 26

Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 27

Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 28

Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 29

BlinkBio Enters into Option agreement with Scripps Research Institute 30

iGenomX Enters into Licensing Agreement with Scripps Research Institute 31

OPKO Health Enters into Licensing Agreement with Scripps Research Institute 31

Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 32

Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 33

Fabrus Enters into Licensing Agreement with Scripps Research Institute 34

Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 35

Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 36

Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 37

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 38

Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 39

Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 40

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 41

OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 41

Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 42

Blackthorn Therapeutics Spin Off from Scripps Research Institute 43

The Scripps Research Institute, Key Competitors 45

The Scripps Research Institute, Key Employees 46

The Scripps Research Institute, Other Locations 47

The Scripps Research Institute, Subsidiaries 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

The Scripps Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16090
Site License
USD 500 INR 32180
Corporate User License
USD 750 INR 48270

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com